SUMO-1 Modification of Histone Deacetylase 1 (HDAC1) Modulates Its Biological Activities
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Histone deacetylation plays a central role in the regulation of genes linked to virtually all biological processes. This modification reaction is dependent on a family of related histone deacetylases (HDACs), which function as key components of large multiprotein complexes involved in the development of normal and neoplastic cells. The mechanisms regulating HDACs and their roles in such processes are not understood, and these form the major focus for the current study. Here, in the course of assessing possible post-translational modifications of HDAC1, we demonstrated that HDAC1 is a substrate for SUMO-1 (small ubiquitin-related modifier) modification in vitro and in vivo. The HDAC1 lysines targeted for modification were identified as C-terminal Lys-444 and Lys-476, which are also present in mammalian HDAC2 and lower vertebrate HDAC1/2 orthologs yet absent from other HDAC family members, pointing to a means of differential regulation among HDAC proteins. Mutation of these target residues (lysine to arginine substitution) profoundly reduced HDAC1-mediated transcriptional repression in reporter assays without affecting HDAC1 ability to associate with mSin3A and eliminated HDAC1-induced cell cycle and apoptotic responses upon overexpression. Together, the results demonstrate that HDAC1 is modified by SUMO-1, and this modification can dramatically affect HDAC1 activity in a number of surrogate biological assays.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, the activities of class I HDACs are regulated by posttranslational modifications to the C-terminal extension, such as sumoylation (David et al., 2002) and phosphorylation (Tsai and Seto, 2002), which may affect their catalytic activities via an allosteric mechanism and/or by altering their complex forming capabilities.”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as David et al., 2002
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lysine 476 at the carboxyl terminus has been shown to be sumoylated and important for enzymatic function of the wild-type protein [20] and the absence of this amino acid in the MommeD5 mutant protein is likely to impair function.”
From A genome-wide screen for modifiers of transgene variegation identifies genes with critical roles in development (2008) · cites this paper as [20]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Histone acetylation and transcriptional regulatory mechanisms
Struhl, K. (1998) · Genes & Development · doi:10.1101/gad.12.5.599 · Cited by 1,815
Retinoblastoma protein recruits histone deacetylase to repress transcription
Brehm, A., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J., & Kouzarides, T. (1998) · Nature · doi:10.1038/35404 · Cited by 1,230
Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells
Marks, P. A., Richon, V. M., & Rifkind, R. A. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1210 · Cited by 1,157
ALTERATION OF NUCLEOSOME STRUCTURE AS A MECHANISM OF TRANSCRIPTIONAL REGULATION
Workman, J. L., & Kingston, R. E. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.545 · Cited by 1,129
Role of the histone deacetylase complex in acute promyelocytic leukaemia
Lin, R. J., Nagy, L., Inoue, S., Shao, W., Miller, W. H., & Evans, R. M. (1998) · Nature · doi:10.1038/35895 · Cited by 1,062
SUMO-1 Modification of IκBα Inhibits NF-κB Activation
Desterro, J. M. P., Rodriguez, M. S., & Hay, R. T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80133-1 · Cited by 1,038
Grignani, F., De Matteis, S., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Ruthardt, M., Ferrara, F. F., Zamir, I., et al. (1998) · Nature · doi:10.1038/35901 · Cited by 1,004
Xue, Y., Wong, J., Moreno, G. T., Young, M. K., Côté, J., & Wang, W. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80299-3 · Cited by 985
Rb Interacts with Histone Deacetylase to Repress Transcription
Luo, R. X., Postigo, A. A., & Dean, D. C. (1998) · Cell · doi:10.1016/s0092-8674(00)80940-x · Cited by 960
Retinoblastoma protein represses transcription by recruiting a histone deacetylase
Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., Le Villain, J. P., Troalen, F., Trouche, D., & Harel-Bellan, A. (1998) · Nature · doi:10.1038/35410 · Cited by 909
Research works printed but not linked: 1
- Bertos, N. R., Wang, A. H. & Yang, X. J. (2001) Biochem. Cell Biol. 79, 243-252 · doi:10.1139/o01-032 · Paper page
Cited by
Items 101–200 of 237
Vigodner, M., Ishikawa, T., Schlegel, P. N., & Morris, P. L. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00527.2005 · Cited by 66
NF-κB Repression by PIAS3 Mediated RelA SUMOylation
Liu, Y., Bridges, R. G., Wortham, A. M., & Kulesz-Martin, M. F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037636 · Cited by 72
“A number of transcriptional repressors are either SUMOylated or capable of binding to the SUMO moiety through the SUMO interacting motif (SIM), including HDAC1 [31], CtBP [32], ZEB1 [26] and CoREST [33].”
BackgroundIssar, N., Roux, E., Mattei, D., & Scherf, A. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01183.x · Cited by 64
“However, other HDACs have been shown to be sumoylated (David et al., 2002; Cheng et al., 2004) with altered biological activity in terms of levels of protein acetylation and/or gene repression.”
BackgroundHeideman, M. R., Lancini, C., Proost, N., Yanover, E., Jacobs, H., & Dannenberg, J.-H. (2014) · Haematologica · doi:10.3324/haematol.2013.092643 · Cited by 75
Rallabhandi, P., Hashimoto, K., Mo, Y. Y., Beck, W. T., MOITRA, P. K., & D’Arpa, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200388200 · Cited by 63
Sumoylation: Implications for Neurodegenerative Diseases
Anderson, D. B., Zanella, C. A., Henley, J. M., & Cimarosti, H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-50044-7_16 · Cited by 70
Regulation of SRC family coactivators by post-translational modifications
Li, S., & Shang, Y. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.02.002 · Cited by 66
SUMOylation of the Corepressor N-CoR Modulates Its Capacity to Repress Transcription
Tiefenbach, J., Novac, N., Ducasse, M., Eck, M., Melchior, F., & Heinzel, T. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-07-0610 · Cited by 66
“Several reports showed that class I (HDAC1, HDAC2) and class II HDACs (HDAC4, HDAC6) are targets for SUMO modification (David et al., 2002; Kirsh et al., 2002; Girdwood et al., 2003; Yang and Sharrocks, 2004).”
BackgroundDifferential Regulation of c-Jun-dependent Transcription by SUMO-specific Proteases
Cheng, J., Perkins, N. D., & Yeh, E. T. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412185200 · Cited by 66
Chemical and genetic control of IFNγ‐induced MHCII expression
Wijdeven, R. H. M., van Luijn, M. M., Wierenga‐Wolf, A. F., Akkermans, J. J. L. L., van den Elsen, P. J., Hintzen, R. Q., & Neefjes, J. (2018) · EMBO Reports · doi:10.15252/embr.201745553 · Cited by 66
EBNA3C Coactivation with EBNA2 Requires a SUMO Homology Domain
Rosendorff, A., Illanes, D., David, G., Lin, J. J., Kieff, E. D., & Johannsen, E. (2003) · Journal of Virology · doi:10.1128/jvi.78.1.367-377.2004 · Cited by 60
“HDAC-1 has been shown to bind to EBNA3C and is activated by sumolation (8, 36).”
BackgroundHyperphosphorylation of Histone Deacetylase 2 by Alphaherpesvirus US3 Kinases
Walters, M. S., Kinchington, P. R., Banfield, B. W., & Silverstein, S. J. (2010) · Journal of Virology · doi:10.1128/jvi.00981-10 · Cited by 60
“HDAC activity is controlled by posttranslational modifications (9, 18, 40, 57), and studies with HSV-1, HSV-2, and VZV showed that HDAC1 and HDAC2 are hyperphosphorylated during virus infection (26, 39, 43, 61).”
BackgroundSerum response factor is modulated by the SUMO-1 conjugation system
Matsuzaki, K., Minami, T., Tojo, M., Honda, Y., Uchimura, Y., Saitoh, H., Yasuda, H., Nagahiro, S., Saya, H., & Nakao, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00910-0 · Cited by 58
Using mass spectrometry to identify ubiquitin and ubiquitin‐like protein conjugation sites
Jeram, S. M., Srikumar, T., Pedrioli, P. G. A., & Raught, B. (2009) · PROTEOMICS · doi:10.1002/pmic.200800666 · Cited by 61
“, stabilize proteins [28], recruit histone deacetylases [29], or recruit transcriptional corepressors [30].”
Fong, P. M., Tian, L., & Chen, Z. J. (2006) · Cell Research · doi:10.1038/sj.cr.7310059 · Cited by 53
Tao, C.-C., Hsu, W., Ma, Y., Cheng, S. J., & Lee, E. H. Y. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2016.161 · Cited by 57
“The present result is consistent with the previous finding that HDAC1 is SUMO-modified at Lys-444 and Lys-476 in the cell.(23) It is also consistent with the result from SUMO Software prediction because Lys-444 and Lys-476 both fit to the sequence of consensus SUMO substrate motif.”
BackgroundResultEckermann, K. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8259-5 · Cited by 58
SUMOylation of FOXP1 regulates transcriptional repression via CtBP1 to drive dendritic morphogenesis
Rocca, D. L., Wilkinson, K. A., & Henley, J. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-00707-6 · Cited by 48
Histone deacetylase activity is retained in primary neurons expressing mutant huntingtin protein
Hoshino, M., Tagawa, K., Okuda, T., Murata, M., Oyanagi, K., Arai, N., Mizutani, T., Kanazawa, I., Wanker, E. E., & Okazawa, H. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01991.x · Cited by 48
“We previously found that small ubiquitin-like modifier-1 (SUMO-1), which regulates HDAC1 activity (David et al. 2002), is increased in neurons of the polyglutamine disease brains (Ueda et al.”
BackgroundNew Insights into the Role of the Small Ubiquitin-like Modifier (SUMO) in Plants
Park, H. J., & Yun, D. (2012) · International review of cytology · doi:10.1016/b978-0-12-405210-9.00005-9 · Cited by 51
A role for paralog-specific sumoylation in histone deacetylase 1 stability
Citro, S., Jaffray, E., Hay, R. T., Seiser, C., & Chiocca, S. (2013) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt032 · Cited by 49
“It has also been shown that HDAC1 is sumoylated on K444 and K476 (Colombo et al., 2002; David et al., 2002), but the clear biological role of this modification is still under investigation.”
Backgroundvan den Burg, H. A., & Takken, F. L. W. (2010) · Plant Signaling & Behavior · doi:10.4161/psb.5.12.13913 · Cited by 47
Conde, J. N., Schutt, W. R., Mladinich, M. C., Sohn, S., Hearing, P., & Mackow, E. R. (2020) · Journal of Virology · doi:10.1128/jvi.01086-20 · Cited by 51
“PML forms complexes containing STAT2 and histone deacetylases (HDAC1/2) that are regulated by protein SUMOylation (42, 66, 67).”
BackgroundSUMO Modification of the Ets-related Transcription Factor ERM Inhibits Its Transcriptional Activity
Degerny, C., Monté, D., Beaudoin, C., Jaffray, E., Portois, L., Hay, R. T., de Launoit, Y., & Baert, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411250200 · Cited by 46
Viral manipulation of cellular protein conjugation pathways: The SUMO lesson
Mattoscio, D. (2013) · World Journal of Virology · doi:10.5501/wjv.v2.i2.79 · Cited by 46
Strategies to Identify Recognition Signals and Targets of SUMOylation
Silva-Ferrada, E. D., Lopitz‐Otsoa, F., Lang, V., Rodríguez, M. S., & Matthiesen, R. (2012) · Biochemistry Research International · doi:10.1155/2012/875148 · Cited by 49
“SUMOylation of transcription repressors and corepressors, seems to be quite a general mechanism to recruit chromatin remodeling and histone-modifying complexes involved in repression [87].”
BackgroundSUMO1 negatively regulates BRCA1-mediated transcription, via modulation of promoter occupancy
Park, M. A., Seok, Y., Jeong, G., & Lee, J. S. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm969 · Cited by 44
“BRCA1 Ring domain (10-109) NLS Activation domain(1528-1863) BRCT domains (I 1640-1729) (II 1760-1821)”
InfluentialThe Ubiquitin-Proteasome System and Memory: Moving Beyond Protein Degradation
Jarome, T. J., & Devulapalli, R. K. (2018) · The Neuroscientist · doi:10.1177/1073858418762317 · Cited by 45
Meng, F., Han, M., Zheng, B., Wang, C., Zhang, R., Zhang, X., & Wen, J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.05.112 · Cited by 43
“HDAC2 is one of the most thoroughly studied HDACs, and can undergo different posttranslational modifications such as phosphorylation [8–10], acetylation [11], ubiquitination [12] and sumoylation [13].”
Backgroundp53 sumoylation: Mechanistic insights from reconstitution studies
Wu, S.-Y., & Cheng, C.-M. (2009) · Epigenetics · doi:10.4161/epi.4.7.10030 · Cited by 46
Lysine Deacetylase (KDAC) Regulatory Pathways: an Alternative Approach to Selective Modulation
Dyke, M. W. V. (2014) · ChemMedChem · doi:10.1002/cmdc.201300444 · Cited by 49
Wotton, D., Pemberton, L. F., & Merrill, J. C. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-50044-7_3 · Cited by 47
“Human HDAC1, a class I HDAC, can be sumoylated at two carboxylterminal lysines ( David et al., 2002 ).”
BackgroundThe methyltransferase Suv39h1 links the SUMO pathway to HP1α marking at pericentric heterochromatin
Maison, C., Bailly, D., Quivy, J., & Almouzni, G. (2016) · Nature Communications · doi:10.1038/ncomms12224 · Cited by 52
Karvonen, U., Jänne, O. A., & Palvimo, J. J. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.06.018 · Cited by 46
Protein SUMOylation in neuropathological conditions
Anderson, D. B., Wilkinson, K. A., & Henley, J. M. (2009) · Drug News & Perspectives · doi:10.1358/dnp.2009.22.5.1378636 · Cited by 45
The function of SUMOylation and its crucial roles in the development of neurological diseases
Chen, X., Zhang, Y., Wang, Q., Qin, Y., Yang, X., Xing, Z., Shen, Y., Wu, H., & Qi, Y. (2021) · The FASEB Journal · doi:10.1096/fj.202002702r · Cited by 39
Miyake, K., & Nagai, K. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.08.018 · Cited by 41
“Furthermore, the proteins associated with DNA-methylation-based gene regulation, such as Dnmt3, Hdac1 and Hdac4, are SUMOylated and interact with each other (Kang et al., 2001; Kirsh et al., 2002; David et al., 2002; Ling et al., 2004).”
Walters, M. S., Erazo, A., Kinchington, P. R., & Silverstein, S. J. (2009) · Journal of Virology · doi:10.1128/jvi.01318-09 · Cited by 40
“It is known that HDAC activity is controlled by posttranslational modifications (8, 38, 49).”
BackgroundTirard, M., Jasbinsek, J., Almeida, O., & Michaelidis, T. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0320825 · Cited by 36
SUMO modification of proteins other than transcription factors
Watts, F. Z. (2004) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2003.12.002 · Cited by 40
SUMO and estrogen receptors in breast cancer
Karamouzis, M. V., Konstantinopoulos, P. A., Badra, F. A., & Papavassiliou, A. G. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9552-5 · Cited by 43
Yang, W.-S., Campbell, M., & Chang, P. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006216 · Cited by 37
The rice SUMO conjugating enzymes OsSCE1 and OsSCE3 have opposing effects on drought stress
Joo, J., Choi, D. H., Lee, Y. H., Seo, H. S., & Song, S. I. (2019) · Journal of Plant Physiology · doi:10.1016/j.jplph.2019.152993 · Cited by 34
Direct and/or Indirect Roles for SUMO in Modulating Alpha-Synuclein Toxicity
Vijayakumaran, S., Wong, M. B., Antony, H., & Pountney, D. L. (2015) · Biomolecules · doi:10.3390/biom5031697 · Cited by 36
“Furthermore, SUMO-dependent recruitment of HDACs by specific proteins has also been demonstrated [74,75,77,78], although the mechanisms of this molecular specificity remain unclear.”
BackgroundMatsuura, T., Shimono, Y., Kawai, K., Murakami, H., Urano, T., Niwa, Y., Goto, H., & Takahashi, M. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.04.022 · Cited by 33
Viral Interplay with the Host Sumoylation System
Wilson, V. G. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-50044-7_21 · Cited by 37
“Inversely, SUMO modification of HDAC enhances its activity ( David et al., 2002 ).”
BackgroundLing, L., & Lobie, P. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400601200 · Cited by 36
Global SUMO Proteome Responses Guide Gene Regulation, mRNA Biogenesis, and Plant Stress Responses
Mazur, M. J., & van den Burg, H. A. (2012) · Frontiers in Plant Science · doi:10.3389/fpls.2012.00215 · Cited by 37
“In a similar manner, plant StUbLs might lift TPL/TPRs- or LUG/SEU-based gene repression sequestering them in larger oligomers.”
BackgroundSUMO Proteases: Redox Regulation and Biological Consequences
Xu, Z., Chan, H., Lam, W. L. M., Lam, K. H., Lam, L. S. M., Ng, T. B., & Au, S. W. N. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2182 · Cited by 31
Kobayashi, S., Shibata, H., Kurihara, I., Yokota, K., Suda, N., Saito, I., & Saruta, T. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0320069 · Cited by 31
“Indeed, there are SUMO consensus sites in several HDACs, and SUMOylation is crucial for the expression of HDAC activities (David et al. 2002, Kirsh et al. 2002). www.endocrinology.org Journal of Molecular Endocrinology (2004) 32, 69–86 Downloaded from Bioscientifica.com at 01/19/2022 09:28:15AM via…”
BackgroundSpengler, M. L., Kennett, S. B., Moorefield, K. S., Simmons, S. O., Brattain, M. G., & Horowitz, J. M. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.06.007 · Cited by 30
Covalent conjugation of Groucho with SUMO-1 modulates its corepressor activity
Ahn, J., Lee, Y.-A., Ahn, J., & Choi, C. Y. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.043 · Cited by 29
“It has been shown that HDAC1 is also modified with SUMO-1 at Lys444 and Lys476, and that this modification affects enzymatic activity [25].”
BackgroundHDAC1 SUMOylation promotes Argonaute-directed transcriptional silencing in C. elegans
Kim, H., Ding, Y., Zhang, G., Yan, Y., Conte, D., Dong, M., & Mello, C. C. (2021) · eLife · doi:10.7554/elife.63299 · Cited by 31
Zarreen, F., & Chakraborty, S. (2020) · Journal of Experimental Botany · doi:10.1093/jxb/eraa406 · Cited by 35
Zhao, Q., Ma, Y., Li, Z., Zhang, K., Zheng, M., & Zhang, S. (2020) · Stem Cells International · doi:10.1155/2020/8835714 · Cited by 33
“Acetylation could promote the SUMOylation of histone H4 [40], and SUMOylation could inhibit acetylation by facilitating the deacetylase activity of some deacetylases such as histone deacetylase (HDAC) 1 [41].”
BackgroundZoumpoulidou, G., Jones, M. C., de Mattos, S. F., Francis, J. M., Fusi, L., Lee, Y., Christian, M., Varshochi, R., Lam, E., & Brosens, J. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0467 · Cited by 29
Sumoylation of histone deacetylase 1 regulates MyoD signaling during myogenesis
Joung, H., Kwon, S., Kim, K. H., Lee, Y.-G., Shin, S., Kwon, D., Lee, Y.-U., Kook, T., Choe, N., Kim, J. C., et al. (2018) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.236 · Cited by 24
Wang, Y., Zhang, J., Wu, L., Liu, W., Wei, G., Gong, X., Liu, Y., Ma, Z., Ma, F., Thiery, J. P., et al. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1018-7 · Cited by 24
SUMOylation and Potassium Channels
Wu, H., Xu, C., Cheng, J., & Qi, Y. (2015) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2015.11.009 · Cited by 22
SUMO proteins in the cardiovascular system: friend or foe?
Shetty, P. M. V., Rangrez, A. Y., & Frey, N. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00689-0 · Cited by 25
Human factors and pathways essential for mediating epigenetic gene silencing
Poleshko, A. S., Kossenkov, A. V., Shalginskikh, N., Pecherskaya, A., Pecherskaya, A., Einarson, M. B., Einarson, M. B., Skalka, A. M., Skalka, A. M., Katz, R. A., et al. (2014) · Epigenetics · doi:10.4161/epi.32088 · Cited by 22
“1286 Epigenetics Volume 9 Issue 9 UBC9/UBE2I.(39) Furthermore, sumoylation has been shown to increase HDAC1 activity.”
BackgroundResultInfluentialSumoylation and transcription regulation at nuclear pores
Texari, L., & Stutz, F. (2014) · Chromosoma · doi:10.1007/s00412-014-0481-x · Cited by 25
“In mammalian cells, mutation of two lysines in HDAC1 decreases its sumoylation and alleviates its repressive activity (David et al. 2002).”
BackgroundHaemophilus influenzae induces steroid-resistant inflammatory responses in COPD
Cosío, B. G., Jahn, A., Iglesias, A., Shafiek, H., Busquets, X., & Agustí, A. G. N. (2015) · BMC Pulmonary Medicine · doi:10.1186/s12890-015-0155-3 · Cited by 24
“Thus, we propose that the reduced activity of HDAC induced by NTHi that we observed in our study is likely to be due to post-translational modifications of HDAC (nitration or phosphorylation) [35, 36].”
Martin, N., Schwamborn, K., Urlaub, H., Gan, B., Guan, J., & Dejean, A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01210-07 · Cited by 25
“FIP200 bound GST-PIASy with the same efficiency as HDAC1, which was used as a positive control (2, 8), but not GST alone (Fig.”
MethodUbiquitin-like protein modifications in prostate and breast cancer
Wu, F., & Mo, Y.-Y. (2006) · Frontiers in bioscience · doi:10.2741/2094 · Cited by 27
“Mutation of two sumoylation sites of HDAC1 greatly reduces HDAC1-mediated transcriptional repression (101).”
BackgroundInfluentialNew Insights into the Role of Histone Deacetylases as Coactivators of Inflammatory Gene Expression
Schmitz, M. L., & de la Vega, L. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5750 · Cited by 20
PIE-1 SUMOylation promotes germline fates and piRNA-dependent silencing in C. elegans
Kim, H., Ding, Y., Lu, S., Zuo, M.-Q., Tan, W. D., Conte, D., Dong, M., & Mello, C. C. (2021) · eLife · doi:10.7554/elife.63300 · Cited by 20
“Acetylation of H3K9 is associated with active transcription (Peterson and Laniel, 2004), and loss of HDA-1 SUMOylation leads to increased transcriptional activity (David et al., 2002).”
BackgroundNavascués, J., Bengoechea, R., Tapia, O., Vaque, J. P., Lafarga, M., & Berciano, M. T. (2007) · Chromosoma · doi:10.1007/s00412-007-0107-7 · Cited by 22
“Conjugation of histone H4 or the histone deacetylese 1 (HDAC-1) with SUMO-1 seems to contribute to transcriptional repression or attenuation (David et al. 2002; Seeler and Dejean 2003; Verger et al. 2003; Shiio and Eisenman 2003).”
BackgroundRoles of Small Ubiquitin-Related Modifiers in Male Reproductive Function
Vigodner, M. (2011) · International review of cytology · doi:10.1016/b978-0-12-386041-5.00006-6 · Cited by 19
SUMOylation modulates transcriptional repression by TRPS1
Kaiser, F. J., Lüdecke, H., & Weger, S. (2007) · Biological Chemistry · doi:10.1515/bc.2007.051 · Cited by 19
“Furthermore, the activity of the HDAC family members HDAC-1 and HDAC-4 can also be enhanced by attachment of SUMO (David et al., 2002; Kirsh et al., 2002; Petrie et al., 2003), which further emphasizes a relevant function of SUMO in gene silencing.”
BackgroundThe Role of Sumoylation in Senescence
Scurr, L. L., Haferkamp, S., & Rizos, H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-50044-7_13 · Cited by 22
“In fact many proteins involved in transcriptional repression, including DNMT3A, HDACs 1 and -4, MCAF1 and MBD1, are susceptible to SUMO modification ( David et al., 2002; Ling et al., 2004; Yang and Sharrocks, 2004; Li et al., 2007; Sekiyama et al., 2008).”
BackgroundSong, Y. J., Chi, D.-Y., Yu, P., Lu, J., Xu, J., Tan, P.-P., Wang, B., Cui, Y., & Chen, H. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00166 · Cited by 18
“…have revealed that SUMO modification plays an important role in the functional regulation of multiple proteins, such as androgen receptor (Bahnassy et al., 2017), NF-kB pathway (Huang et al., 2003), p53 (Brandl et al., 2012), and HDAC (David et al., 2002; Citro et al., 2013; Wagner et al., 2015).”
BackgroundRegulation of SUMOylation on RNA metabolism in cancers
Cao, Y., Huang, C., Zhao, X., & Yu, J. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1137215 · Cited by 17
“SUMOylation of HDAC1/HDAC4 enhances their histone deacetylase activity, leading to the transcriptional repression (David et al., 2002; Kirsh et al., 2002).”
BackgroundEpigenetics and the neurodegenerative process
Słowikowski, B. K., Owecki, W., Jeske, J., Jezierski, M., Draguła, M., Goutor, U., Jagodziński, P. P., Kozubski, W. P., & Dorszewska, J. (2024) · Epigenomics · doi:10.2217/epi-2023-0416 · Cited by 18
HDAC1 in axonal degeneration: A matter of subcellular localization
Kim, J. Y., & Casaccia, P. (2010) · Cell Cycle · doi:10.4161/cc.9.18.12716 · Cited by 21
SUMO conjugation and cardiovascular development
Wang, J. (2009) · Frontiers in bioscience · doi:10.2741/3304 · Cited by 16
Pfammatter, S., Bonneil, É., McManus, F. P., & Thibault, P. (2018) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-018-1917-y · Cited by 21
Gao, S., Zeng, X., Wang, J., Xu, Y., Yu, C. W., Huang, Y., Wang, F., Wu, K., & Yang, S. (2021) · Cells · doi:10.3390/cells10113001 · Cited by 15
“This motif is found within the C-termini of human HDAC1 and HDAC2 (two SUMOylated proteins) [19].”
BackgroundHo, J., & Watts, F. Z. (2003) · Biochemical Journal · doi:10.1042/bj20021645 · Cited by 14
Hacker, D. L., Derow, E., & Wurm, F. M. (2005) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2005.01.006 · Cited by 13
Yang, S., Sun, Y., & Yu, W. (2025) · Cells · doi:10.3390/cells14141116 · Cited by 15
“Some studies have shown that HDAC1 undergoes SUMOylation at its C-terminus, which plays an important regulatory role in its transcriptional inhibition activity [189].”
Lee, W.-P., Jena, S., Doherty, D. F., Ventakesh, J., Schimdt, J., Furmick, J. K., Widener, T., Lemau, J., Jurutka, P. W., & Thompson, P. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089506 · Cited by 11
Gupta, R. V., & Kumar, P. (2021) · ACS Omega · doi:10.1021/acsomega.1c05827 · Cited by 20
Hua, D., & Wu, X. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114227 · Cited by 10
Rivera, O., Sharma, M., Dagar, S., Shahani, N., Ramírez-Jarquín, U. N., Crynen, G. C., Karunadharma, P. P., McManus, F. P., Bonneil, É., Thibault, P., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05181-8 · Cited by 11
“Thus, Rhes may alter HDAC1 activity via SUMOylation at lysine 89 and at lysine 476, which is a catalytically essential residue involved in gene repression [72–74].”
BackgroundMiao, S., Dai, X., Li, X., Chen, Z., Wang, Y., Ye, T., Ying, Y., Yu, Y., Wu, A., Song, H., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02909-8 · Cited by 13
Pharmacodynamic markers for histone deacetylase inhibitor development
Heinzel, T., & Krämer, O. H. (2007) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2008.06.003 · Cited by 13
Regulation of Histone Deacetylase Activities and Functions by Phosphorylation and Dephosphorylation
Seto, E., & Yang, X. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00286-2 · Cited by 10
Histone Deacetylation in Alzheimer’s Diseases (AD); Hope or Hype
Ateya, N. H., Al-Taie, S. F., Jasim, S. A., Uthirapathy, S., Chaudhary, K., Rani, P., Kundlas, M., Naidu, K. S., Amer, N. A., & Ahmed, J. K. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01670-0 · Cited by 8
Use of epigenetic regulation for the discovery of fungi derived cryptic natural product
Wang, Y., Guo, J., Zhong, J., & Xiao, H. (2024) · Process Biochemistry · doi:10.1016/j.procbio.2024.06.015 · Cited by 8
The impact of dysregulation SUMOylation on prostate cancer
Li, K., Wang, H., Jiang, B., & Jin, X. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06271-2 · Cited by 8
“Histone deacetylase 1 (HDAC1), an AR co-repressor, is similarly modified by SUMO1 at K444 and K476 sites [64].”
Epigenetic transitions: towards therapeutic targets
Kalebic, T. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.6.693 · Cited by 8
“Functional activities of HDAC, including transcriptional repression, appear to be controlled by posttranslational modifications, such as sumoylation [31,32].”
BackgroundEarly Thyroid Hormone-induced Gene Expression Changes in N2a-β Neuroblastoma Cells
Bedó, G., Pascual, A., & Aranda, A. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9389-y · Cited by 6
Histone Deacetylase Inhibitors in APL and Beyond
Petrie, K. R., Prodromou, N. V., & Zelent, A. (2007) · Springer eBooks · doi:10.1007/978-3-540-34594-7_10 · Cited by 8
“HDAC activity may also be modulated by sumoylation, with HDAC1 modified at Lys444 and Lys476 [36, 43], and HDAC4 at Lys559 [143].”
BackgroundAnalysis of Histone Deacetylases Sumoylation by Immunoprecipitation Techniques
Wagner, T., Godmann, M., & Heinzel, T. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6527-4_25 · Cited by 5
Meunier, D., & Seiser, C. (2006) · Humana Press eBooks · doi:10.1385/1-59745-024-3:3 · Cited by 5
Assessing the Role of Paralog-Specific Sumoylation of HDAC1
Citro, S., & Chiocca, S. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6527-4_24 · Cited by 4
DNA Methylation and Histone Deacetylation: Interplay and Combined Therapy in Cancer
Qiu, Y., Shabashvili, D., Li, X., Kumari, P., Chen, M., & Zajac‐Kaye, M. (2012) · InTech eBooks · doi:10.5772/35977 · Cited by 4
“Other modifications of HDAC1 include sumoylation and ubiquitylation, which also influence deacetylase activity and protein stability (David et al., 2002,Oh et al., 2009).”
BackgroundSUMO Tasks in Chromatin Remodeling
García‐Domínguez, M. (2013) · InTech eBooks · doi:10.5772/55395 · Cited by 3
Epigenetic biomarkers in toxicology
Aliberti, A., & Barile, F. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404630-6.00042-7 · Cited by 5
Metadata
- Authors
- David, G., Neptune, M. A., & DePinho, R. A.
- Affiliations
- Harvard University (US)
- Corresponding author
- DePinho, Ronald A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-06
- Volume
- 277
- Issue
- 26
- Pages
- 23658-23663
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2129063436
- Cited by
- 236
- References
- 36
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 4 · 2023: 2 · 2022: 2 · 2021: 6 · 2020: 5 · 2019: 6 · 2018: 6 · 2017: 9 · 2016: 5 · 2015: 7 · 2014: 11 · 2013: 11 · 2012: 7
- FWCI
- 7.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6719 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- American Cancer Society
- National Institutes of Health
- National Cancer Institute (R01CA086379)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- SUMO1, HDAC1, post-translational modification, lysine modification, histone deacetylation, transcriptional repression, mSin3A, cell cycle regulation, apoptosis, HDAC2
- MeSH terms
- Animals, Histone Deacetylases, Lysine, Structure-Activity Relationship, 3T3 Cells, Ubiquitin, SUMO-1 Protein, Mice, Histone Deacetylase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.